Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Cancer Discovery
|
March 28, 2020
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
Junji Tsurutani, Hiroji Iwata, Ian Krop, et al.
Molecular Cancer Therapeutics
|
September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells
Sidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Cancers
|
May 28, 2022
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
Julie E Bauman, Ricklie Julian, Nabil F Saba, et al.
Targeted Oncology
|
March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
Trisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Clinical and Translational Radiation Oncology
|
October 6, 2025
In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy
Anna Kirstein, Dan Ionascu, Michael A S Lamba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
Pankaj B Desai, Aniruddha S Karve, Misam Zawit, et al.
Cancers
|
October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Kate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Haematologica
|
October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Keith W Pratz, Jason Kaplan, Moshe Levy, et al.
Nucleic Acids Research
|
June 10, 2011
The human DEK oncogene regulates DNA damage response signaling and repair
Gina M Kavanaugh, Trisha M Wise-Draper, Richard J Morreale, et al.
JCO Precision Oncology
|
October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma
Gianna Kroening, Jia Luo, Mark G Evans, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Cancer Discovery
|
March 28, 2020
Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
Junji Tsurutani, Hiroji Iwata, Ian Krop, et al.
Molecular Cancer Therapeutics
|
September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells
Sidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Cancers
|
May 28, 2022
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer
Julie E Bauman, Ricklie Julian, Nabil F Saba, et al.
Targeted Oncology
|
March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
Trisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Clinical and Translational Radiation Oncology
|
October 6, 2025
In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy
Anna Kirstein, Dan Ionascu, Michael A S Lamba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2024
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
Pankaj B Desai, Aniruddha S Karve, Misam Zawit, et al.
Cancers
|
October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Kate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Haematologica
|
October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Keith W Pratz, Jason Kaplan, Moshe Levy, et al.
Nucleic Acids Research
|
June 10, 2011
The human DEK oncogene regulates DNA damage response signaling and repair
Gina M Kavanaugh, Trisha M Wise-Draper, Richard J Morreale, et al.
JCO Precision Oncology
|
October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma
Gianna Kroening, Jia Luo, Mark G Evans, et al.
Page
of 8